comes assessed showed significantly large results [12] [13] [14] [15] [16] [17] . Physical outcomes such as fitness and functional wellbeing showed smaller effects than psychological outcomes, and results were inconsistent [12, 14, 15] . Previous meta-analyses and reviews of randomized controlled trials (RCTs) found, in part, medium to large effects of yoga on symptoms of anxiety in cancer patients [12, 14, 15] . Effects were rather consistent across studies and amounted to a pooled standardized mean difference (SMD) of -0.76 [12] . Depression also showed large and consistent effects (SMD -0.95) in a meta-analysis of RCTs [12] . Furthermore, large consistent effects of yoga on the level of stress have been found in RCTs (SMD -0.95) [12] . Effects on fatigue have also been found, albeit with less consistency and of smaller magnitude [12, 15] . Concerning quality of life, yoga therapy revealed only a positive trend [12, 15] . However, many of the previous studies were small, lacked a control group, and included only selected tumor entities, in particular breast cancer patients. Although homogeneity may be regarded as an asset, participants of yoga therapy in clinical settings represent a large range of tumor entities which could all profit from yoga. So far, no study on a heterogeneous cancer sample has been conducted in Germany.
Therefore, the aim of the present study was to evaluate the effect of yoga therapy on symptoms of anxiety, depression, and fatigue in a prospective, randomized, controlled trial in patients with various tumor diseases in a clinical setting. We chose symptoms of anxiety and depression as our primary outcomes as both are highly prevalent in cancer patients and previous research has shown anxiety and depression to be amenable to yoga therapy. We chose fatigue as a secondary outcome because, although very prevalent and debilitating for cancer patients, only small effects of yoga therapy were described in previous research.
Patients and Methods

Organization of the Study
In this randomized controlled intervention study, which was performed at the University Hospital of Würzburg, Comprehensive Cancer Center Mainfranken (CCC MF), cancer patients regardless of their specific tumor were included consecutively. Inclusion criteria in addition to presence of a cancer disease were age 18 years and voluntary participation in the study. Recruitment was carried out on the basis of informatory presentations provided by the CCC MF which were held every 3 months as well as by directly addressing cancer patients in psycho-oncological care at the University Hospital of Würzburg. Eligible patients were informed personally by E. Jentschke and provided with an information sheet before they gave written consent to participate in the study and external randomization took place. Yoga therapy in the intervention group consisted of 60-min sessions once a week over a period of 8 weeks. During these 8 weeks, participants in the control group did not receive any yoga therapy, but were offered yoga therapy thereafter. Both groups completed the T1 questionnaire after having given consent to participate in the study. The T2 questionnaire was filled in at the end of the last yoga lesson in the intervention group and before starting the first yoga lesson in the control group. The study complies with the Declaration of Helsinki and was approved by the ethics committee of the University Medical Center of Würzburg.
Yoga Therapy
The yoga treatment was conducted in groups of 10-12 patients. Lessons were initiated by a short conversation about the participants' mental and physical condition and by some relaxation. After that, several exercises of gentle Hatha Yoga, inspired by Jon Kabat Zinn [18] , were carried out, always in the same sequence, under supervision and giving correction if necessary. Sessions concluded with meditation. Part of these exercises were selected positions (asanas) such as the warrior or breathing exercises, and so-called pranayamas such as the breathing circuit. Each participant also received a CD and a printed manual for motivating independent practice. The extent of the participants' own practice at home was also discussed at the end of the intervention.
Questionnaires
We chose anxiety and depression as the primary outcomes and fatigue as the secondary outcome.
Anxiety
To determine the intensity of anxiety symptoms, the reliable and valid selfreported Generalized Anxiety Disorder (GAD-7) scale was used. Its 7 items refer to the period of the past 2 weeks and can be answered with 'not at all', 'on individual days', 'on more than half the days', or 'almost every day'. The total score of the GAD-7 ranges from 0 to 21, with higher values indicating more severe anxiety symptoms, and the cut-off is 10 [19] .
Depression
To measure symptoms of depression, the reliable and valid Patient Health Questionnare-2 (PHQ-2) was used. This is a shortened version of the Patient Health Questionnaire-9 and consists of the 2 core symptoms of a depressive episode -depressed mood and loss of interest and joy -in the previous 2 weeks. Possible answers are 'not at all', 'on individual days', 'on more than half the days', and 'almost every day'. The total score of the PHQ-2 is 6, with higher values indicating more severe depressive symptoms, and the cut-off is 3 [20, 21] .
Fatigue
To measure cancer-related fatigue, the European Organisation for Research and Treatment of Cancer Fatigue scale (EORTC QLQ-FA13) was used, which belongs to the EORTC quality of life questionnaires. Its 13 items are assigned to 3 dimensions: emotional, physical, and cognitive fatigue. Response options are 'not at all', 'a little', 'quite a bit', and 'very much', which leads to a point system of 1-4. Scores are transformed to a scale ranging from 0 to 100. Higher values indicate more severe fatigue symptoms [22, 23] .
Statistical Analysis
We conducted a power calculation based on a between-group standardized mean difference of 0.76 as presented in a meta-analysis by Lin et al. (2011) [12] and setting α to 0.05 and β to 0.20, which produced a number of 29 cases per group. Descriptive statistics presented include mean, standard deviation, range, and relative frequency, as appropriate. ANCOVA with adjustment for the baseline scores of the outcomes was performed for testing between-group effects in primary and secondary outcomes. We present eta² effect sizes as produced by ANCOVA, with eta² = 0.0099 considered a small, eta² = 0.0588 a medium, and eta² = 0.1379 a large effect. A two-sided p value of < 0.05 was considered significant. IBM SPSS Version 22 (IBM Corp., Armonk, NY, USA) was used.
Results
Clinical Data
A total of 70 patients participated in the study, 37 in the intervention group and 33 in the control group. 62 (89%) of the patients were women. The average age was 58 years (standard deviation (SD) = 13, range 24-80 years), and 57% were married. 81% of the participants had more than a basic education. The most common tumor diagnosis was breast cancer (49%) followed by lymphoma/leukemia (11%) and colorectal cancer (10%) (table 1). The average time since the pri-mary diagnosis was 24 months. About one-tenth of the patients had a recurrence, and in one-fifth metastases were diagnosed. Approximately half of the participants were in active treatment for their tumor disease during the study period. The number of patients who received tumor treatment during the study was higher in the intervention group than in the control group. The number of dropouts amounted to 6 persons. The reason for dropout remained unknown for 5 participants, and 1 patient died during the study period.
Effects on Outcomes
Compared to the control group, the intervention group showed a significantly lower anxiety value at the post-intervention time point after adjusting for baseline values (p = 0.005). The effect size was large (eta² = 0.122). Regarding depression and fatigue, smallto-medium non-significant effects were found (depression: eta² = 0.026, p = 0.21; fatigue: eta² = 0.042, p = 0.11). The mean values of both GAD-7 and PHQ-2 were lower than the respective cut-offs in both groups at both measurement occasions (table 2) .
Yoga Practice
Of the intervention group, 31% had experience with yoga before starting the yoga intervention, and 97% practiced yoga at home during the intervention. 7% of the intervention group practiced yoga daily, 19% 3-5 times a week, 29% 1-2 times a week, and 45% occasionally.
Evaluation of Yoga Therapy
Yoga therapy was evaluated very positively by the participants. 'Group size' (10-12 patients), 'duration of the intervention' (60 min), and 'overall structure of the yoga therapy' were rated as 'very good' or 'good' by all participants. Specifically, two-thirds rated the group size as 'very good' and one third as 'good'. Duration was rated as 'very good' by 79% and 'good' by 21%. 94% stated that they were very satisfied with the yoga therapy. Only the therapy length (8 weeks) was occasionally criticized as being too short. 47% rated the length as 'very good' or 'good', 30% as 'satisfactory' or 'sufficient', and 12% were dissatisfied with the length. For 91% of the participants, yoga therapy met their expectations. 97% would participate in this kind of therapy in the future, and also 97% would recommend yoga therapy to other patients.
Utilization of Other Interventions
During the intervention period, a quarter of both the intervention group and the control group participants utilized psychotherapy, and every 4th to 5th patient took part in a self-help group. 70% of the intervention group practiced some form of relaxation exercises compared to 38% of the control group, and 79% of the intervention group did sports compared to 47% of the control group. Note: Due to rounding errors, the sum of the percentages may not always amount to 100%.
Discussion
In this randomized controlled trial, we found a large significant effect of yoga therapy on anxiety symptoms in cancer patients with mixed diagnoses.
Only few studies can be directly compared with these results. Most studies included 1 tumor entity only (especially breast cancer), recruited a sample which was too small for showing significant results, or were not designed as an RCT. Furthermore, different assessment instruments were used in the individual studies, making comparisons difficult.
Psychological Outcomes
Anxiety
We found a large effect size, as compared to a meta-analysis of 10 RCTs with yoga therapy for cancer patients (7 in breast cancer patients, 1 in patients with lymphoma, and 2 in a mixed tumor population) which showed a medium-sized effect on anxiety symptoms. However, in the studies reviewed, different yoga styles and therapies were used [12] .
A large effect on anxiety was also found in a systematic review of 12 RCTs in breast cancer patients in which 7 of the 12 RCTs where organized as a yoga intervention group versus a control group that did not obtain an intervention. In the other 5 studies, the yoga group was controlled by other supportive therapies. It should be noted that this meta-analysis was based on studies with breast cancer patients only and this result was found only in patients who were undergoing tumor treatment at the time of the intervention [14] .
Depression
The effect on symptoms of depression was small-to-medium and non-significant in our study. This somewhat contradicts the results of previous studies [12, 14, 15] . In the previously described review of 12 RCTs with yoga therapy for breast cancer patients, a large and significant effect was also found on depression. However, the results should be treated with caution due to potential selection bias in the respective studies [14] .
Another meta-analysis of 10 RCTs with yoga therapy for cancer patients also showed a significant effect on depression, in contrast to our study. However, when interpreting this inconsistency, the use of different assessments should be taken into account [12] . We used the PHQ-2 for measuring depressive symptoms, a very short questionnaire consisting of only 2 items, which may have lacked sufficient sensitivity to change.
However, by combining individual studies, meta-analyses achieve a higher power than individual studies. Thus, the non-significant effect on symptoms of depression in the current study may be due to our small sample size. Furthermore, a floor effect may explain this result, which means that the study sample showed low levels of depression (i.e., the mean value was lower than the cutoff) that were hardly amenable to further reduction. Further studies should employ a larger number of participants or only patients with an increased level of depressive symptoms.
Fatigue
There was no effect of our yoga intervention on the secondary outcome, fatigue. This result is similar to a meta-analysis of 19 RCTs on yoga therapy in patients with fatigue, which showed only a small effect [24] . The studies reviewed included not only cancer patients but also patients with fibromyalgia, chronic pancreatitis, multiple sclerosis, asthma, and dialysis. However, the effect was present in cancer patients. No effect on fatigue was found in the meta-analysis described above on 10 RCTs of yoga therapy in cancer patients [12] .
Strengths and Limitations
This study was an RCT, lending our results more credibility than those of studies that lacked a control group. Participants of the control group were offered yoga therapy after completion of the 8-week yoga therapy in the intervention group. This ensured high compliance with the study in the control group.
Another advantage of our study was the inclusion of different tumor entities. As already mentioned, many of the published studies were restricted to breast cancer patients [25] . Breast cancer patients tend to be more depressed [26] and may also be more open to alternative treatment approaches [25] . Both may explain the good response of breast cancer patients to yoga therapy. In our study, half of the patients had breast cancer, while a large proportion of subjects suffered from other cancers. Nevertheless, we Note: T1 = baseline, T2 = post-intervention; descriptive statistics are for the total sample; p values and eta2 come from ANCOVA adjusted for baseline scores based on samples with data at both T1 and T2. N = Number; M = median; SD = standard deviation. found an effect of yoga therapy in our sample with mixed diagnoses. However, long-term effects of yoga therapy are also of interest. While we showed a short-term effect on symptoms of anxiety, future studies should examine whether this effect is maintained for a longer period. Some limitations are acknowledged. The generalizability of the study is limited by the high proportion of women. With a share of 90% of women, a conclusion as to the effects in men is not possible. The high level of participation of women reflects the generally higher tendency of women to use CAM [27] . In addition, 50% of participants were breast cancer patients, which limits the generalizability to other cancers. Furthermore, generalizability is limited by the fact that many participants had at least secondary school qualifications, and more educated people tend to use CAM [25] .
The positive effect on anxiety must be viewed with caution since we used no active control group. A 3-armed study including an active control group would have been preferable to identify specific effects of yoga.
The therapy period lasted 8 weeks. The fact that the intervention group practiced yoga at home could be considered as a factor influencing the effects as well as an indicator of acceptance of the yoga therapy. Although effects were achieved during this time, a longer therapy may have produced larger effects. Furthermore, with 70 patients, the number of participants was relatively small. This may be a reason why the smaller effects on fatigue and depression did not prove significant.
Patients were broadly recruited without major exclusion criteria. This led to a considerable variance in tumor diagnoses. A possible bias may thus have been caused by the different tumor therapy approaches in individual patients. For example, patients who were started on chemotherapy during yoga therapy may well have had the impression that they benefitted from yoga, but were limited in their well-being by the new chemotherapy. In addition, a larger proportion of participants in the intervention group than in the control group were in active tumor treatment at the end of yoga therapy, with 70% of the intervention group compared to 46% of the control group.
Conclusion
Studies have shown that yoga can be helpful to cope with the psychological burden of a tumor disease. We found a large effect of yoga on anxiety but no effect on depression and fatigue. Although our study was an RCT, thus extending previous work, it lacked an active control group necessary to ensure the effects shown to be specific to yoga. Possible effects on anxiety, depression, and fatigue should be investigated in larger 3-armed studies and over a longer period of time.
